Next generation proteomics for oncology research: A mass spectrometry complementary approach

This webinar is organised by Olink in collaboration with NAPI Project Manager Tuula Nyman. Learn more about the platforms available from Olink and how they can benefit your research projects.

Running order

- Introduction to webinar: Tuula Nyman (10 min)

How this webinar came about, info about what the PCF offers

- Sandra Kyrk: Introduction to PEA technology (10 min)

- Marijana Rucevic: Oncology case study with Scientific affairs (20 mins)

Combined Mass Spectrometry and PEA based plasma proteomic approaches identify common and distinctive biomarkers for cancer immunotherapy

- Stefan Enroth PhD, Docent (Uppsala University, Sweden) (20 min)
High-precision biomarkers for Ovarian Cancer: Experiences with Olink Explore

- Q&A (15 min)

- Closing remarks (Sandra Kyrk) (5min)

 

What you will learn

Introduction to Proximity Extension Assay (PEA) technology for human proteomic analysis

Complement Mass Spectrometry based proteomic analysis to identify common and distinctive biomarkers for cancer immunotherapy

Proteomic approaches in plasma and serum samples to identify common and distinctive biomarkers

Identify high-precision biomarkers for Ovarian Cancer using Olink Explore

 

Registration is free of charge. More details can be found on the Olink registration page.

 

Published May 31, 2022 1:50 PM - Last modified May 31, 2022 1:50 PM